Founding fundraiser says Addenbrooke’s would not be what it is today without financial support of hospital charity
This month, Addenbrooke's Charitable Trust celebrates its 30th birthday. As the official charity for Addenbrooke’s, it funds high-tech equipment, specialist staff, extra comforts and vital research above and beyond what the NHS is able to provide. Here, one of the founding fundraisers, retired Professor of Radiology Adrian Dixon, talks about his early days of fundraising for the first whole body…
New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects
For the first time, scientists have systematically studied the genetic effects of chemotherapy on healthy tissues. Researchers from the Wellcome Sanger Institute, the University of Cambridge, Cambridge University Hospitals NHS Foundation Trust (CUH) and their collaborators analysed blood cell genomes from 23 patients of all ages who had been treated with a range of chemotherapies.
Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery
Study identifies new metrics to enhance scRNA-seq based virtual cell modellingFoundational paper to drive development of improved virtual cell models for rejuvenation target discoveryCambr
4basebio introduces new branding to reflect next phase of growth enabling development of advanced genetic therapies
4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today (01 July 2025) announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success in this rapidly advancing field.
A scientist's view: Why marketing matters for science
A scientist and our Advisory Board Member Farah Aladin-Foster, shares why marketing is crucial for extending the reach of your research beyond academic journals and making a bigger impact in the science and tech community.
Radiotherapy and surgical ablation technologies for cancer treatment
Radiotherapy, or radiation ablation, has evolved significantly since its inception. Ongoing technological advancements have the potential to position radiotherapy as a first-line “surgical” treatment for solid tumours by enhancing its precision and efficacy. Further advancements in real-time imaging, adaptive dosing and advanced delivery techniques could give radiotherapy the potential to…
Achieve ISO Certification with expert guidance
Looking to implement or integrate ISO Standards in your business?
Guardtech Group set for Suffolk Business Awards showcase to kick off trio of events
The Haverhill-based contamination control specialists are up for the Large Business of the Year prize next month before setting their sights on two more awards later in the year.
25 years since the completion of the human genome project and the future of genomics
As it marks 25 years since the Human Genome Project, the Sanger Institute looks to a future where genomics drives better health and prevents disease.
Cambridge Cognition investment, Monument Therapeutics, achieves positive Phase I results for novel schizophrenia treatment
Cambridge Cognition (AIM: COG), the brain health software group specialising in digital health products that advance brain health research and treatment, is pleased to report that Monument Therapeutics, in which the Group has a 20% holding, has achieved positive topline results from its Phase I clinical trial of MT1988, a novel treatment for cognitive impairment associated with schizophrenia …
Zyme Communications celebrates 15 years of providing specialist support for the life science sector
Zyme Communications Ltd. (Zyme), the life science specialist PR and marketing agency, today (26 June 2025) celebrates its 15-year anniversary, and introduces refreshed branding to reflect this milestone and the Company’s continued development.
CUH lands double funding win for technology
Two cutting-edge medical technologies from Addenbrooke's to tackle brain injury are among 35 awarded a share of £3m from the National Institute for Health and Care Research (NIHR).
NIHR BioResource Scientific Conference 2025 goes live today!
Our event platform is now open for you to log in! Please use the email you registered with and set a password. We will kick off the live event at 9.30am but before then, please have a look around, get familiar with the site and check out the available resources.
Unpick your Overwhlem - New 1:1 offer from Promote Mental Health
This month we launch a new service at Promote Mental Health. An opportunity to work one to one with Claire Harris unpicking your stress and overwhelm, and coming away with personalised strategies to address the chaos.
Stronger together in wireless innovation
Stronger Together in Wireless InnovationZinwave and Wilson Connectivity share a commitment to providing intelligent, future-ready indoor wireless solutions.
An Introduction to Claire Harris and Promote Mental Health
The benefit of networking is the excitement of making new contacts, and catching up with existing connections, some I can now call great friends. This post is an introduction to me and what I do at Promote Mental Health.
Enhanced Genomics and The ALBORADA Drug Discovery Institute partner to accelerate Alzheimer's drug discovery
Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced a strategic partnership with The ALBORADA Drug Discovery Institute at the University of
OutSee raises £1.8M seed funding to expand therapeutic pipeline using predictive genomics
Financing led by Ahren Innovation Capital with additional investment from Kadmos Capital, Empirical Ventures and Panacea VenturesInvestment to leverage OutSee’s proprietary AI-based predictive genomics technology, Nomaly, to expand and progress in-house target developme
Stop leaving money on the table: A guide to managing your leads better
Discover how smart lead management can double conversions and transform missed opportunities into revenue for science marketers.
Mental Health First Aid - How to get it right
Mental Health First Aid in the workplace. How to get it right.
The art of feedback without the drama. Master the give-and-take game
Feedback is the backbone of personal and professional growth, yet it remains one of the most difficult communication acts to master. When done right, it builds trust, strengthens teams, and fuels continuous improvement. When done poorly, it can damage morale, create resentment, and shut down future dialogue. At the core of effective feedback is communication—clear, empathetic, and responsive…
Cerberus Therapeutics Enters into Antibody Discovery Agreement with Isogenica to Advance Immune-Modulating Therapies
Isogenica Ltd., The VHH Company™, today announced an antibody discovery agreement with Cerberus Therapeutics to support the development of targeted immune-modulating therapies using single-domain antibodies. This agreement brings together Cerberus’s KappaLink™ platform — designed to engage Fc receptor-positive (FcR+) effector cells via circulating immunoglobulins — with Isogenica’s expertise…
UK-China Life Sciences Forum in London: Fostering practical collaboration
On 10 June 2025, the “Sino-UK Pharmaceutical Cooperation Partnering Conference” convened at the Millennium Gloucester Hotel in London, providing a valuable forum for professionals and organisations from both the UK and China to explore new opportunities in life sciences and healthcare innovation. Hosted by China Medical City (CMC) of Taizhou, the event welcomed a diverse group of government…